Voß, F.; van Beek, L.F.; Schwudke, D.; Ederveen, T.H.A.; van Opzeeland, F.J.; Thalheim, D.; Werner, S.; de Jonge, M.I.; Hammerschmidt, S.
Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines 2020, 8, 310.
https://doi.org/10.3390/vaccines8020310
AMA Style
Voß F, van Beek LF, Schwudke D, Ederveen THA, van Opzeeland FJ, Thalheim D, Werner S, de Jonge MI, Hammerschmidt S.
Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines. 2020; 8(2):310.
https://doi.org/10.3390/vaccines8020310
Chicago/Turabian Style
Voß, Franziska, Lucille F. van Beek, Dominik Schwudke, Thomas H. A. Ederveen, Fred J. van Opzeeland, Daniela Thalheim, Sidney Werner, Marien I. de Jonge, and Sven Hammerschmidt.
2020. "Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection" Vaccines 8, no. 2: 310.
https://doi.org/10.3390/vaccines8020310
APA Style
Voß, F., van Beek, L. F., Schwudke, D., Ederveen, T. H. A., van Opzeeland, F. J., Thalheim, D., Werner, S., de Jonge, M. I., & Hammerschmidt, S.
(2020). Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines, 8(2), 310.
https://doi.org/10.3390/vaccines8020310